Case Study: Breast Cancer Disintegrating with CDS - 70 Days of Treatment
Physician Report
- Condition:** Breast Cancer
- Treatment:** CDS (Chlorine Dioxide)
- Duration:** 70 days
- Documentation:** Daily photographic progression from Day 1 to Day 70
Background
The patient underwent CDS treatment for breast cancer with daily photographic documentation tracking the disintegration of the tumor over a 70-day period. The images document the progression starting from Day 1 and continuing through Day 70, showing the tumor's response to CDS treatment.
Treatment Protocol
The patient applied CDS treatment over 70 days with photographic documentation taken daily. The images show:
- Day 1: Initial condition before treatment
- Day 70: Final condition after 70 days of treatment
- Progression: Tumor disintegration visible throughout the treatment period
The documentation shows the tumor disintegrating progressively over the 70-day treatment period, with clear visual evidence of the CDS treatment's effect on the cancerous tissue.
Results
After 70 days of CDS treatment, the breast cancer tumor showed significant disintegration. The photographic documentation provides clear visual evidence of:
- Progressive tumor reduction
- Tissue disintegration
- Healing response to CDS treatment
- Complete documentation from Day 1 to Day 70
The patient's case demonstrates the potential of CDS treatment for breast cancer with comprehensive visual documentation of the tumor's response over a 70-day period.
Clinical Significance
This case is particularly significant because:
- **Daily Documentation:** Complete photographic record from Day 1 to Day 70 provides objective evidence of treatment response
- **Tumor Disintegration:** Visual evidence of tumor breakdown over time
- **Breast Cancer Application:** CDS treatment applied to breast cancer, a serious and potentially life-threatening condition
- **Long-Term Treatment:** 70-day treatment period shows sustained response
- **Patient Self-Management:** Treatment administered by patient with CDS protocol
Source
Personal testimonial shared in the Universal Antidote Telegram community.